ROSIA reaches the final phase with two contractors

ROSIA reaches the final phase with two contractors

ROSIA reaches the final phase with two contractors

ROSIA reaches the final phase with two contractors

ROSIA, the European pre-commercial public procurement project for telerehabilitation in remote areas, has successfully entered the third and final phase of the R&D competition with two contractors awarded.

Zaragoza, 20June 2024. ROSIA (Remote Rehabilitation  Service for Isolated Areas) has successfully awarded the third phase of the R&D competition for the field testing of two solutions to be validated by three public procurers: Servicio Aragonés de Saluin Spain, Centro Hospitalar e Universitário de Coimbra in Portugal, and the National Rehabilitation Hospital in Ireland.

Rehabilitation in remote areas creates many difficulties for patients and families, is often insufficient, and this situation reduces the quality of life of patients in the long term and may even lead to avoidable disabilities. Existing technologies may be of help, but their integration into the procedures and infrastructure of public health systems makes them impractical. ROSIA targets this unmet need. Through an open platform, that includes a catalogue of apps and services, the contractors are creating an ecosystem of developers to address this need. ROSIA also addresses the organisational change required for the adoption of telerehabilitation, facilitating the implementation of integrated care models.

The awarded solutions to be tested in Phase 3 are:

REHABILIFY is the proposal of a Spanish Consortium Led by the Spanish technology centre Fundació Eurecat, which also involves two other Spanish entities, the SME Doole Health, and the Germans Trias i Pujol research centre (IGTP)

RAISE will be developed by an international consortium Led by the Greek entity CERTH (Centre For Research And Technology Hellas, Ethniko Kentro), which also integrates the Spanish TELEVES, IBV and Vidavo, the Greek Research Committee University Ioannina (UoI) and the Portuguese INESCTEC.

The total budget for this Phase 3 will be €2.367.940,96 (including 21% VAT) to be shared between both contractors.

– Pre-commercial public procurement is a phased R&D competition in which several public administrations define a common unmet need that is not yet covered by the market.

– Phase 1 focused on the detailed design of the solution, phase 2 on the development of the prototype and phase 3 on the validation of the complete solution. The total budget to be distributed between contractors in the three phases was €3.9 million

– Project ROSIA PCP was launched in January 2021 and involves 12 partners across 5 countries:

The project is coordinated by IACS (Instituto Aragonés de Ciencias de la Salud) and supported by eight other entities with complementary profiles: VALDE (Spain), Instituto Pedro Nunes – IPN (Portugal), The International Foundation for Integrated Care – IFIC (The Netherlands), The Decision Group (The Netherlands), Instituto para la Experiencia del Paciente – IEXP (Spain), PPCN Aps (Denmark) and the Municipalities Penela and Soure in Portugal. The three public procurers are: Servicio Aragonés de Saluin Spain, Centro Hospitalar e Universitário de Coimbra in Portugal, and the National Rehabilitation Hospital in Ireland.

PCP Execution Phases

PCP Execution Phases

PCP Execution Phases

PCP Execution Phases

The ROSIA PCP will implement an effective and efficient methodological approach to ensure the successful preparation and conduction of the pre-commercial procurement and to lay the foundations for large-scale procurement of the fully developed ROSIA solutions after the duration of the PCP.

PCP Execution Phases

Pre-commercial procurement (PCP) is the procurement of research and development of new innovative solutions before they are commercially available. PCP involves different suppliers competing through different phases of development. The risks and benefits are shared between the procurers and the suppliers under market conditions. PCP Execution Phases

Public procurers involved in the ROSIA project have the common goal to deliver disruptive solutions to support effective implementation of scalable and cost-effective telerehabilitation solutions for people living in rural areas requiring long-term and tailored rehabilitation treatments, throughout the implementation of a Pre-Commercial Procurement scheme (PCP). The project will make progress towards this aim by stimulating the demand and creating a robust framework for practical PCP outcomes within the project duration. This will also promote innovation in Europe, via demand through the PCP, which has, so far, been an under-utilized tool.

The ROSIA PCP process will start with an extensive preparation stage and is followed by the execution stage organized in three development phases. The preparation stage (PHASE 0) includes the Prior information Notice Publication (PIN) and the Open Market Consultation (OMC).

The execution stage will consist of: a joint PCP procurement process and the implementation, in three phases, of the PCP contracts under the supervision of the buyers’ group, ensuring execution of the R&D services by the providers according to the action plan, implementation, and requirements defined in the preparation stage.

  • PHASE 1 Solution design will develop the feasibility study of selected solutions from awarded bidders. Duration: 3 months
  • PHASE 2 Prototyping development of most promising solutions from PHASE 1. Duration: 8 months
  • PHASE 3 Pre-commercial small scale solution deployment – Field test. Validation of best prototyped solutions in real life scenario at each procurer site. Duration: 18 months.

PCP Execution Phases